Region: Global
Category: Therapeutic Area

Global Therapeutic Area

(6,734 reports matching your criteria)
  • Ophthalmic Femtosecond Lasers

    ... at a CAGR of 4.6% over the analysis period 2024-2030. Consumables & Accessories, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$666.4 Million by the end ... Read More

  • Sexual Enhancers

    ... CAGR of 7.7% over the analysis period 2024-2030. Male Sexual Enhancers, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$354.9 Million by the end of the ... Read More

  • Tobacco Alternative Gums

    ... at a CAGR of 6.0% over the analysis period 2024-2030. 2 mg, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$3.5 Billion by the end of ... Read More

  • Family Planning Centers

    ... at a CAGR of 3.3% over the analysis period 2024-2030. Birth Control Clinics, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$4.5 Billion by the end ... Read More

  • Neurology Devices

    ... CAGR of 5.9% over the analysis period 2024-2030. Cerebrospinal Fluid Management, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$7.1 Billion by the end of the ... Read More

  • Extracorporeal CO2 Removal Devices

    ... 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Extracorporeal CO2 Machines, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$89.9 Million by ... Read More

  • Pneumonia Therapeutics

    ... CAGR of 6.7% over the analysis period 2024-2030. Drugs, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$6.8 Billion by the end of the analysis period. ... Read More

  • Sperm Banks

    ... CAGR of 5.3% over the analysis period 2024-2030. Sperm Storage, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$4.2 Billion by the end of the analysis ... Read More

  • Heart Valve Repair and Replacement Devices

    ... reach US$40.9 Billion by 2030, growing at a CAGR of 15.4% over the analysis period 2024-2030. Transcatheter Surgery, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach ... Read More

  • Ophthalmic Pharmaceutical Drugs

    ... at a CAGR of 3.6% over the analysis period 2024-2030. Anti-VEGF Agents, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$34.3 Billion by the end of ... Read More

  • Cosmetic Procedures and Products

    ... 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Facial Injectable, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$22.1 Billion by the ... Read More

  • Bulk Paclitaxel

    ... CAGR of 8.5% over the analysis period 2024-2030. Semi-Synthetic Paclitaxel API, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$139.1 Million by the end of the ... Read More

  • Antidepressants

    ... 2.5% over the analysis period 2024-2030. Major Depressive Disorder, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$7.0 Billion by the end of the analysis period. ... Read More

  • Ovulation Test

    ... CAGR of 4.0% over the analysis period 2024-2030. Urine, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.2 Billion by the end of the analysis period. ... Read More

  • Cancer Cachexia Global Market Report 2025

    ... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More

  • Veterinary Renal Disease Global Market Report 2025

    ... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More

  • Prostate Cancer Nuclear Medicine Diagnostics Global Market Report 2025

    ... cancer nuclear medicine diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More

  • Veterinary Eye Care Global Market Report 2025

    ... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More

  • Stroke Management

    ... CAGR of 5.3% over the analysis period 2024-2030. Diagnostics Type, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$35.9 Billion by the end of the analysis ... Read More

  • Vitreous Tamponades

    ... CAGR of 3.0% over the analysis period 2024-2030. Gaseous Tamponades, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$50.9 Million by the end of the analysis ... Read More

  • Knee Braces

    ... CAGR of 5.2% over the analysis period 2024-2030. Functional, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$875.4 Million by the end of the analysis period. ... Read More

  • Botulinum Toxin

    ... CAGR of 8.8% over the analysis period 2024-2030. Type A, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$11.0 Billion by the end of the analysis ... Read More

  • Liver Cancer Drugs

    ... at a CAGR of 18.4% over the analysis period 2024-2030. Targeted Drug Therapy, one of the segments analyzed in the report, is expected to record a 18.4% CAGR and reach US$5.1 Billion by the end ... Read More

  • Migraine Drugs

    ... CAGR of 16.0% over the analysis period 2024-2030. Acute Treatment, one of the segments analyzed in the report, is expected to record a 16.6% CAGR and reach US$7.2 Billion by the end of the analysis ... Read More

  • Melanoma Therapeutics

    ... CAGR of 13.7% over the analysis period 2024-2030. Cutaneous Melanoma, one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach US$4.3 Billion by the end of the analysis ... Read More

Cookie Settings